IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Nov 9, 2023 · 10-Q · 40 days after period end · 0000950170-23-062018
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$7.17M | -$7.40M | -$3.39M | -$1.68M |
| EPS Diluted | -$0.23 | -$0.34 | -$0.25 | -$0.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 9, 2023 · 40 d after period end
